(RTTNews) - IO Biotech (IOBT) has opened the door to a potential merger, asset sale, or even dissolution as it evaluates "a range of strategic alternatives," a move that underscores the pressure ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...